About the journal
Pharmaceutical Fronts is an open-access journal published by Georg Thieme Verlag KG in Germany, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 15 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Georg Thieme Verlag KG
- ISSN
- 2628-5088 · 2628-5096
- Country
- Germany
- Languages
- english
- Access
- Open access
- Articles in DOAJ
- 191
- Declared review time
- 15 weeks
- Declared peer-review model
- double_blind
- Official website
- https://lp.thieme.de/journals/pharmaceutical-fronts/2628-5088
Index listings
- DOAJ · 2020-11-30
- Indexing
- DOAJ
- APC
- —
- Declared review time (DOAJ)
- 15 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
191
Most recent article
last month
Average review time (journal-declared via DOAJ)
15weeks
Works in OpenAlex
211
Last recorded publication year
2025
h-index
12
i10-index
16
From OpenAlex open data (CC0).
Editorial & policy11
- Last DOAJ review date
- 2026-07-24
- Added to DOAJ
- 2020-11-30
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-09-21
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 89%
- ORCID iDs in current deposits
- 0%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- Peer-review policy
- View policy
Identity & continuity2
- Alternate titles
- Chinese journal of Pharmaceutical B
- Source type
- journal
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Innovative Microfluidic and Catalytic Techniques Innovation
- Innovative Microfluidic and Catalytic Techniques Innovation
- Drug Solubulity and Delivery Systems
- Chemical Synthesis and Analysis
- Chemical Synthesis and Analysis
- Computational Drug Discovery Methods
- Computational Drug Discovery Methods
- Drug Solubulity and Delivery Systems
Show all subjects (50)
- Chemical Synthesis and Reactions
- Chemical Synthesis and Reactions
- Synthesis and biological activity
- Synthesis and biological activity
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Biochemical and Molecular Research
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
- Cancer therapeutics and mechanisms
- Analytical Methods in Pharmaceuticals
- Analytical Chemistry and Chromatography
- Biochemical and Molecular Research
- Advanced Drug Delivery Systems
- Analytical Methods in Pharmaceuticals
- Nanoparticle-Based Drug Delivery
- Inhalation and Respiratory Drug Delivery
- Histone Deacetylase Inhibitors Research
- Inhalation and Respiratory Drug Delivery
- Cancer therapeutics and mechanisms
- Advanced Drug Delivery Systems
- Protein Degradation and Inhibitors
- Nanoparticle-Based Drug Delivery
- Advancements in Transdermal Drug Delivery
- Enzyme Catalysis and Immobilization
- Nanomaterials for catalytic reactions
- Analytical Chemistry and Chromatography
- Peptidase Inhibition and Analysis
- Advancements in Transdermal Drug Delivery
- Metabolomics and Mass Spectrometry Studies
- Enzyme Catalysis and Immobilization
- Nanomaterials for catalytic reactions
- Peptidase Inhibition and Analysis
- Glycosylation and Glycoproteins Research
- Phytochemicals and Antioxidant Activities
- CAR-T cell therapy research
- CAR-T cell therapy research
- Phytochemicals and Antioxidant Activities
- Metabolomics and Mass Spectrometry Studies
- Asymmetric Hydrogenation and Catalysis
- Glycosylation and Glycoproteins Research
- Asymmetric Hydrogenation and Catalysis
Keywords (DOAJ)
- pharmacology
- pharmaceutical chemistry
- medical chemistry
- organic chemistry
- pharmacy
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ